|
CN112209930A
|
|
Istradefylline derivative and preparation method and application thereof
|
|
CN112159338A
|
|
Preparation of triphenyldiamidine impurity
|
|
CN111892603A
|
|
Separation and purification method of caffeine impurity II
|
|
CN111763989A
|
|
Single crystal preparation method of caffeine impurity I
|
|
CN111910256A
|
|
Single crystal preparation method of caffeine impurity II
|
|
CN111892602A
|
|
Separation and purification method of caffeine impurity I
|
|
CN111658622A
|
|
Oral instant film agent containing ibuprofen inclusion compound and preparation method thereof
|
|
CN111707750A
|
|
HPLC detection method for related substances of sodium salicylate
|
|
CN111650322A
|
|
Method for detecting methyl acetoacetate in cefradine
|
|
CN111707752A
|
|
HPLC detection method of chlordiazepam related substances
|
|
CN111689898A
|
|
Method for separating analgin impurity
|
|
CN111707751A
|
|
HPLC detection method for tramadol hydrochloride impurity E
|
|
CN111574462A
|
|
Preparation method of sodium 5-ethyl-5-phenyl barbiturate
|
|
CN111606862A
|
|
Preparation and purification method of 5-ethyl-5-isoamyl malonylurea
|
|
CN111537655A
|
|
Liquid chromatography detection method of 1, 3-diphenyl-1-triazene in edaravone
|
|
CN111484427A
|
|
Preparation method of high-purity 1, 4-bis [ bis (2-cyanoethyl) amino ] butane
|
|
CN111562326A
|
|
Method for detecting impurities in hydrocortisone intermediate by HPLC
|
|
CN111303036A
|
|
Synthetic method of analgin impurity
|
|
CN111484457A
|
|
Method for separating alogliptin impurities
|
|
CN111300865A
|
|
Screw extrusion dehydrator and application
|
